# MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia

> **NCT07492771** · PHASE1 · NOT_YET_RECRUITING · sponsor: **MicrobiotiX Co., Ltd** · enrollment: 18 (estimated)

## Conditions studied

- Pneumonia - Bacterial
- Pseudomonas Aeruginosa Infection

## Interventions

- **BIOLOGICAL:** MP101
- **DRUG:** Antibiotics

## Key facts

- **NCT ID:** NCT07492771
- **Lead sponsor:** MicrobiotiX Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-15
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07492771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07492771, "MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07492771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*